NGEN Nervgen Pharma Corporation
Health Care, filed as NERVGEN PHARMA CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
- 1 Owner
- Max 0.4%
- $2.2M
- 1 new
In 2026 Q2 Nathan Fischel opened a position in Nervgen Pharma.
Who owns this now
Largest portfolio weights among holders, up to 0.4% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.
Who owns NGEN
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| Nathan Fischel, Dafna Capital Management | New 0.41% | 1,050,000 | $2.2M | History |
SEC filings
Recent issuer filings from EDGAR, 15 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 6-K/A | FORM 6-K/A | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc | |
| 6-K | FORM 6-K | Filing Doc |
No filings match this filter.
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.